Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biolog Announces Appointment of Distributors in Europe

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
New distributors to cover sales and marketing of Biolog’s innovative product lines.

New distributors were announced by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification of diverse cell types, from bacteria to human cells.

The distributors and their respective territories are IUL Instruments GmbH, Koningswinter, Germany (Germany and Austria), Awel International, Blain, France (France), A&LCO Industries, Cologno, Italy (Italy), and IUL S.A., Barcelona, Spain (Spain).

According to Barry Bochner, CEO & CSO at Biolog, "The distributors were selected as being most qualified to provide local supply, technical and service support to our customers in these countries."

Biolog's flagship product is the GEN III MicroPlate™, a test panel that can be used for identifying over 1,300 species of bacteria and covering human pathogens, animal pathogens, plant pathogens, and typical environmental bacteria.

Phenotype MicroArrays™, the company's most advanced product line, have diverse applications ranging from basic genetic and cellular research to cancer studies, drug and toxicology studies, and bioprocess optimization.

Biolog's product lines also include advanced instrumented systems such as the OmniLog® and MicroStation™ that automatically read and help to interpret the phenotypic data that is generated.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Discovery demonstrates advantage of metabolic over genetic screening.
Friday, June 07, 2013
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Sanger Institute, St Jude Data-Sharing Agreement
Childhood cancer targeted by Sanger Institute and St Jude Children’s Research Hospital exchanges of cancer data
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!